“…Many molecules, including α7 acetylcholine receptor (α7AChr) ( Kanno et al, 2013 ), inositol 1,4,5-trisphosphate receptor type 1 (IP3R1) ( Zhang et al, 2003 ; Fukatsu et al, 2004 ; Fukatsu et al, 2006 ; Fiedler and Nathanson, 2011 ), GluR1/4 13,14 , GluK1/2/3 15,16 , metabotropic glutamate receptor 8 (mGluR8) ( Rose et al, 2008 ), K-Cl co-transporter 2 (KCC2) ( Li et al, 2007 ; Horn et al, 2010 ), D2 and D3 dopamine receptors (D2/3Rs) ( Binda et al, 2002 ; Kabbani and Levenson, 2006 ), Ca2 + -calmodulin serine kinase (CASK) ( Cohen et al, 1998 ; Biederer and Sudhof, 2001 ; Mburu et al, 2006 ), nuclear mitotic apparatus (NuMA) ( Ye et al, 1999 ; Ilies et al, 2012 ), phosphoinositide 3 kinase enhancer (PIKE) ( Ye et al, 2000 ), inositol hexakisphosphate kinase 2 (IP6K2) ( Nagpal et al, 2018 ), cell adhesion molecule (CAM) 1/3 29,30 , βII spectrin ( Wang et al, 2018 ), flotillin-1 32 , pp1 ( Wang et al, 2016 ), and 14-3-3 34-36 , have been identified as 4.1N binding partners. Although 4.1N performs different functions depending on specific tissue localization, 4.1N predominantly functions as a scaffolding protein in signaling transduction by locating, supporting, and coordinating multiple partners.…”